Art Unit 1642
Group 1640Immunology
- Active examiners
- 23
- Average office actions per grant
- 2.16
Grant ratio
- Art Unit 1642
- 51.0%
- Group 1640
- 55.8%
Active examiners
| Sean E Aeder | 51.7% | 2.45 | October 2026 |
|---|---|---|---|
| Laura B. Goddard | 46.5% | 2.15 | October 2026 |
| Peter J. Reddig | 58.0% | 2.44 | October 2026 |
| Yan Xiao | 61.9% | 2.00 | October 2026 |
| Mark Halvorson | 46.2% | 2.16 | October 2026 |
| Nelson B Moseley Ii | 60.2% | 1.83 | October 2026 |
| Michael D Allen | 31.7% | 3.19 | August 2026 |
| Karl J. Puttlitz | 63.0% | 2.14 | October 2026 |
| Julie Wu | 66.0% | 2.35 | October 2026 |
| Cheng Lu | 35.6% | 2.09 | October 2026 |
| Lisa V. Cook | 59.1% | 1.92 | October 2026 |
| Alyssa Rae Stonebraker | 25.1% | 1.49 | October 2026 |
| Dennis John Sullivan | 34.0% | 1.73 | October 2026 |
| Misook Yu | 20.1% | 1.58 | October 2026 |
| Brandon J. Fetterolf | 60.7% | 1.65 | October 2026 |
| Sarah A Alsomairy | 58.7% | 1.94 | October 2026 |
| Yie-Chia Lee (Tonya) | 5.7% | 1.00 | September 2026 |
| Josephine K Darpolor | 5.7% | 1.00 | August 2026 |
| Samira Jean-Louis | 41.2% | 1.77 | September 2026 |
| Jessica M Priest | 0.0% | N/A | October 2026 |
| Liliana Cerullo | 0.0% | 1.00 | October 2026 |
| Maureen Driscoll | 0.0% | 1.57 | October 2026 |
| Minjal Jitendrakumar Pancholi | 0.0% | N/A | October 2026 |
Examiner distribution
- Median grant ratio
- 46.4%
- Middle 50% of grant ratios
- 30.1%–59.4%
- Median office actions / grant
- 1.94
- Middle 50% of office actions / grant
- 1.69–2.16
Active examiners with at least 20 applications.
Other associated examiners
Examiners without recent activity.
| Lei Yao | 57.2% | 1.86 | May 2026 Potentially inactive |
|---|---|---|---|
| Kauser M. Akhoon | 61.3% | 2.18 | April 2020 Appears inactive |
| Anne Holleran | 55.8% | 2.16 | August 2017 Appears inactive |
| Minh-Tam Davis | 48.4% | 1.38 | July 2010 Appears inactive |
| Christine L Harris | 0.0% | N/A | August 2025 Appears inactive |
| Latia Denise Saine | 100.0% | 2.00 | March 2024 Appears inactive |
Based on available public USPTO records; may be incomplete.